Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, sold ORKA on Oct 12, 2026
Data as of Oct 16
▼ SELL$170K2,100 shares at $80.76Arjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.
- Traded
- Oct 12, 2026
- Disclosed
- Oct 13, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ORKA since disclosure
−8.0%
after the sale
Similar stocks (XLV) since disclosure
+4.2%
XLV — its sector index fund
Change in closing price from Oct 13, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$459Kdisclosed Oct 13 · filed 1 day after the trade
- ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$160Kdisclosed Oct 13 · filed 1 day after the trade
- ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$16.6Kdisclosed Oct 13 · filed 1 day after the trade